Open AccessProvider Assessment of Adherence to HIV Antiretroviral Therapy
Author(s) -
David R. Bangsberg,
Frederick Hecht,
Heather Clague,
Edwin D. Charlebois,
Daniel Ciccarone,
Margaret A. Chesney,
Andrew R. Moss
Publication year - 2001
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-200104150-00005
Subject(s) - amprenavir , abacavir , didanosine , efavirenz , medicine , mycophenolic acid , ritonavir , viral load , gastroenterology , pharmacology , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , biology , transplantation , biochemistry , protease , hiv 1 protease , enzyme
Adherence assessment is an essential component of monitoring HIV antiretroviral therapy. Prior studies suggest that medical providers frequently estimate individual patient adherence inaccurately.